| Human NKG2D/CD314 Protein (LTP10817) |
| LTP10817 |
| 100ug |
|
$406 In stock |
| NKG2D is a type II transmembrane glycoprotein having an extracellular lectin-like domain. This domain lacks the recognizable calcium-binding sites found in true C-type lectins and binds protein rather than carbohydrate ligands. Human NKG2D is expressed on CD8 alpha beta T cells, gamma ? T cells, NK cells and NKT cells. |
| Recombinant Human NKG2D/CD314 Protein is expressed from Expi293 with His tag and Avi tag at the N-terminal. It contains Phe78-Val216. |
| NKG2D/CD314 |
| Human |
| P26718 |
| Phe78-Val216 |
| The protein has a predicted MW of 19.0 kDa. Due to glycosylation, the protein migrates to 36-38 kDa based on the Tris-Bis PAGE result. |
| Immobilized Human NKG2D, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Anti-NKG2D Antibody, hFc Tag with the EC50 of 6.6ng/ml determined by ELISA. The affinity constant of 95.15 nM as determined in SPR assay (Biacore T200). See testing image for detail. |
| N-His-Avi |
| Expi293 |
| > 95% as determined by Tris-Bis PAGE |
| Less than 1EU per ug by the LAL method. |
| Lyophilized from 0.22 um filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as a protectant before lyophilization. |
| Reconstituted protein stable at -80 C for 12 months, 4 C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
| Shipped at ambient temperature. |
| Centrifuge tubes before opening. Reconstituting to a concentration of more than 100 ug/ml is recommended. Dissolve the lyophilized protein in distilled water. |
| |